n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Cardiomegaly in 4 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
Cardiomegaly: Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, H | 1 |
Gao, S | 2 |
Ye, J | 1 |
Feng, X | 1 |
Cai, Y | 1 |
Liu, Z | 1 |
Lu, J | 1 |
Li, Q | 1 |
Huang, X | 1 |
Chen, S | 1 |
Liu, P | 1 |
Park, BM | 1 |
Cha, SA | 1 |
Kim, SH | 1 |
LaPointe, MC | 1 |
Mendez, M | 1 |
Leung, A | 1 |
Tao, Z | 1 |
Yang, XP | 1 |
Vanecková, I | 1 |
Skaroupková, P | 1 |
Dvorák, P | 1 |
Certíková Chábová, V | 1 |
Tesar, V | 1 |
Bader, M | 1 |
Ganten, D | 1 |
Kramer, HJ | 1 |
4 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Cardiomegaly
Article | Year |
---|---|
COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
Topics: Animals; Animals, Newborn; Calcineurin; Cardiomegaly; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 | 2014 |
Attenuation of renovascular hypertension by cyclooxygenase-2 inhibitor partly through ANP release.
Topics: Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Cyclo | 2015 |
Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse.
Topics: Animals; Cardiomegaly; Collagen; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhib | 2004 |
Effects of sodium restriction and cyclooxygenase-2 inhibition on the course of hypertension, proteinuria and cardiac hypertrophy in Ren-2 transgenic rats.
Topics: Animals; Animals, Genetically Modified; Blood Pressure; Body Weight; Cardiomegaly; Cyclooxygenase In | 2005 |